RxDoctor Payments Data

Monica McBryde

Nurse Practitioner · Hurricane, WVNPI 1790388288

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,895 and has fallen 91.6% since, to $159 in 2024. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,741in general payments, 2019–2025

Across 187 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$657
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$637
  • Intercept Pharmaceuticals, Inc.$219
  • Takeda Pharmaceuticals U.S.A., Inc.$174
  • Supernus Pharmaceuticals, Inc.$172
  • Gilead$170
  • plus $713 from 8 others

What the payments were for

  • Food & beverage$2,741100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,741 in reported general payments places this provider in the 90th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Medicare billing

Part B allowed, 2024
$13,515
Medicare patients
132
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate18$495
Famotidine15$276
Fluticasone Propionate34$254
Doxycycline Hyclate33$173
Methylprednisolone29$158
Cefdinir13$153
Losartan Potassium16$107
Cyclobenzaprine Hcl21$95
Prednisone16$22

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Hurricane

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →